Daily

Survey: Which hospitals and biomed research institutes generated the most licensing revenue last year?

Licensing revenue from universities, hospitals, medical schools and life science research institutes is on the rise, according to a new survey from the Association of University Technology Managers. Revenue increased 6.8 percent in 2012 to $2.6 billion. The amount of income they’re generating from licensing deals has been helped by running royalties which increased more […]

Licensing revenue from universities, hospitals, medical schools and life science research institutes is on the rise, according to a new survey from the Association of University Technology Managers. Revenue increased 6.8 percent in 2012 to $2.6 billion.

The amount of income they’re generating from licensing deals has been helped by running royalties which increased more than 30 percent to $1.9 billion in 2012. It’s significant because it shows that discoveries by these institutions are hitting the market. The number of licenses that generated running royalties rose by more than 5 percent to 9,640.

An analysis of technology transfer data showed that they produced 705 startups last year, a 5 percent increase.

The survey also showed that institutions are finding alternatives to federal and industrial funding. The “All Other”  category rose by $1.8 billion or 10.7 percent.

Among the 194 institutions that responded to the survey, 161 are universities and 32 are hospitals and research institutes.

Here are the top 10 hospitals and research institutions by 2012 licensing income and the number of startups each of them formed in the same year.

City of Hope Medical Center and Beckman Research Institute: $224.4 million; startups: 1

sponsored content

A Deep-dive Into Specialty Pharma

A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.

Memorial-Sloan Kettering Cancer Center: $143.2 million; startups: 2

Mount Sinai School of Medicine: $76 million

Mayo Foundation for Medical Education and Research: $28.75 million;

startups: 5

Wistar Institute: $17.76 million

Cedars Sinai Medical Center: $17.2 million; startups: 1

Fred Hutchinson Cancer Research Center: $10.4 million; startups: 1

Boston Children’s Hospital: $10.2 million

Brigham and Women’s Hospital: $8.9 million; startups: 7

Baylor College of Medicine: $8 million; startups: 4